SEI Investments
CLVS

SEI Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

SEI Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,874
Closed -$144K – 2863
2019
Q1 		$144K Sell
5,874
-1,314
-18% -$32.9K ﹤0.01% 2393
2018
Q4 		$128K Buy
7,188
+7,169
+37,732% +$146K ﹤0.01% 2141
2018
Q3 		$0 Sell
19
-1,166
-98% -$45.1K ﹤0.01% 3600
2018
Q2 		$54K Sell
1,185
-2,442
-67% -$119K ﹤0.01% 2491
2018
Q1 		$192K Sell
3,627
-6,752
-65% -$394K ﹤0.01% 1913
2017
Q4 		$706K Sell
10,379
-1,349
-12% -$94.3K ﹤0.01% 1585
2017
Q3 		$966K Sell
11,728
-511
-4% -$40.5K ﹤0.01% 1466
2017
Q2 		$1.15M Buy
12,239
+7,529
+160% +$461K ﹤0.01% 1387
2017
Q1 		$300K Sell
4,710
-2,690
-36% -$164K ﹤0.01% 1694
2016
Q4 		$329K Buy
7,400
+6,062
+453% +$213K ﹤0.01% 1674
2016
Q3 		$48K Buy
+1,338
New +$28.7K ﹤0.01% 2071
2016
Q1 		– Sell
-11
Closed – – 2682
2015
Q4 		$0 Sell
11
-13,767
-100% -$888K ﹤0.01% 2737
2015
Q3 		$1.27M Buy
+13,778
New +$1.19M 0.01% 974

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

SEI Investments's CLVS Position: Q2 2019 in Review

SEI Investments sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 5,874 shares — an estimated $144K sold.

SEI Investments first reported a position in CLVS in Q3 2015 and held it in 13 quarters. The position peaked at $1.27M in Q3 2015. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • SEI Investments reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • SEI Investments sold 5,874 Clovis Oncology, Inc. shares in Q2 2019, an estimated $144K.
  • SEI Investments first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 13 quarters.
  • SEI Investments's Clovis Oncology, Inc. position peaked at $1.27M in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on SEI Investments's 13F filing for Q2 2019, filed 14 Aug 2019.